167 related articles for article (PubMed ID: 32477528)
1. Development of keloidal morphea after treatment with cyclosporine in a case of recalcitrant generalized morphea.
Dadkhahfar S; Asadi Kani Z; Araghi F; Moravvej H
Clin Case Rep; 2020 May; 8(5):837-839. PubMed ID: 32477528
[TBL] [Abstract][Full Text] [Related]
2. Nodular/Keloidal Scleroderma with No Systemic Involvement-A Case Report and a Review of the Literature.
Trufin II; Ungureanu L; Halmágyi SR; Apostu AP; Șenilă SC
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731191
[TBL] [Abstract][Full Text] [Related]
3. Nodular morphea (NM): report of a case of concurrent NM and morphea profunda associated with limited type systemic sclerosis, and overview and definition for NM.
Ohata C; Yasunaga M; Tsuruta D; Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Hashimoto T
Eur J Dermatol; 2013; 23(1):87-93. PubMed ID: 23400240
[TBL] [Abstract][Full Text] [Related]
4. Keloid morphea and nodular scleroderma: two distinct clinical variants of scleroderma?
Rencic A; Brinster N; Nousari CH
J Cutan Med Surg; 2003; 7(1):20-4. PubMed ID: 12362259
[TBL] [Abstract][Full Text] [Related]
5. Nodular Scleroderma Revisited: Systemic Sclerosis Presenting as Annular Keloidal Sclerotic Plaques.
Lortscher DN; Cohen PR; Bangert CA; Paravar T
J Clin Aesthet Dermatol; 2016 Jun; 9(6):56-7. PubMed ID: 27386053
[TBL] [Abstract][Full Text] [Related]
6. Keloidal Scleroderma: Case Report and Review.
Kassira S; Jaleel T; Pavlidakey P; Sami N
Case Rep Dermatol Med; 2015; 2015():635481. PubMed ID: 26697236
[TBL] [Abstract][Full Text] [Related]
7. [Nodules on localized scleroderma or morphea].
Bayle P; Bazex J; Marguery MC; Lamant L
Ann Dermatol Venereol; 2005 Feb; 132(2):130-2. PubMed ID: 15798562
[TBL] [Abstract][Full Text] [Related]
8. Nodular (keloidal) scleroderma.
Sanchez NG; Rebollo Domínguez N; Martínez Luna E; Villaseñor Ovies P
Reumatol Clin (Engl Ed); 2023 Oct; 19(8):463-464. PubMed ID: 37805259
[TBL] [Abstract][Full Text] [Related]
9. Questions raised by a case of adult-onset linear nodular scleroderma.
Marcelus C; Jimenez A; Zussman J; Hansen CB; Sontheimer RD
Dermatol Online J; 2022 Oct; 28(5):. PubMed ID: 36809134
[TBL] [Abstract][Full Text] [Related]
10. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
Arif T; Masood Q; Singh J; Hassan I
BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
[TBL] [Abstract][Full Text] [Related]
11. Nodular morphea.
Kauer F; Simon JC; Sticherling M
Dermatology; 2009; 218(1):63-6. PubMed ID: 19005241
[TBL] [Abstract][Full Text] [Related]
12. Nodular morphea keloidal type: A rare case with paradigmatic histopathology significantly accompanied by a flawless surgical scar.
Castelli E; Orlando E; Pardo N; Turdo A; Pistone G; Bongiorno MR
J Cutan Pathol; 2021 Nov; 48(11):1329-1334. PubMed ID: 33258515
[No Abstract] [Full Text] [Related]
13. Linear indurated plaque over the neck.
K S; Thakur V; Sethy M; Sahu DK; Behera B
Int J Dermatol; 2024 Apr; ():. PubMed ID: 38615334
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma with Nodular Scleroderma.
Srisuttiyakorn C; Aunhachoke K
Case Rep Dermatol; 2016; 8(3):303-310. PubMed ID: 27920682
[TBL] [Abstract][Full Text] [Related]
15. Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review.
McGaugh S; Kallis P; De Benedetto A; Thomas RM
Dermatol Ther; 2022 Jun; 35(6):e15437. PubMed ID: 35278019
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic and therapeutic problems of scleroderma].
Pogorzelska-Antkowiak A; Antkowiak R
Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
[TBL] [Abstract][Full Text] [Related]
17. Generalized morphea as the first sign of breast carcinoma: a case report.
Desmond BL; Blattner CM; Young Iii J
Dermatol Online J; 2016 Feb; 22(2):. PubMed ID: 27267193
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of morphea and systemic sclerosis.
Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y
Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037
[TBL] [Abstract][Full Text] [Related]
19. Morphea With Keloidal Features: A Case Report and Review of the Literature.
Yu D; Ibarra BS; Akkurt ZM; Ahn C; Sangüeza OP
Am J Dermatopathol; 2020 Oct; 42(10):766-768. PubMed ID: 32149834
[TBL] [Abstract][Full Text] [Related]
20. Gene Expression Signatures in Inflammatory and Sclerotic Morphea Skin and Sera Distinguish Morphea from Systemic Sclerosis.
Chen HW; Zhu JL; Martyanov V; Tsoi LC; Johnson ME; Barber G; Popovich D; O'Brien JC; Coias J; Cyrus N; Malviya N; Florez-Pollack S; Kunzler E; Hosler GA; Gudjonsson JE; Khanna D; Whitfield M; Jacobe HT
J Invest Dermatol; 2023 Oct; 143(10):1886-1895.e10. PubMed ID: 37028702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
